Lanean...
Recent progress on rapid SARS-CoV-2/COVID-19 detection by CRISPR-Cas13-based platforms
The limitations of conventional diagnostic procedures, such as real-time PCR-based methods and serological tests, have led the scientific community to innovate alternative nucleic acid detection approaches for SARS-CoV-2 RNA, thereby addressing the dire need for increased testing. Such approaches ai...
Gorde:
| Argitaratua izan da: | Drug Discov Today |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Elsevier Ltd.
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8216859/ https://ncbi.nlm.nih.gov/pubmed/34147688 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drudis.2021.06.005 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|